2023
DOI: 10.1016/j.redox.2023.102606
|View full text |Cite
|
Sign up to set email alerts
|

Myosin light-chain 4 gene-transfer attenuates atrial fibrosis while correcting autophagic flux dysregulation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 45 publications
0
4
0
Order By: Relevance
“…Finally, regarding Myl4, it is worth noting that previous studies have reported that loss-of-function models of Myl4 exhibit morphological and electrical remodeling, leading to the development of arrhythmias. 41,42 Therefore, SNPiP may play a protective role in cardiac functions by upregulating Myl4 to suppress these remodeling processes.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Finally, regarding Myl4, it is worth noting that previous studies have reported that loss-of-function models of Myl4 exhibit morphological and electrical remodeling, leading to the development of arrhythmias. 41,42 Therefore, SNPiP may play a protective role in cardiac functions by upregulating Myl4 to suppress these remodeling processes.…”
Section: Discussionmentioning
confidence: 99%
“…Since only limited information regarding NO and NOS levels in the hearts of EdnrB -/+ mice is available, further investigation is warranted to address this issue and provide a more comprehensive level of understanding. Finally, with regard to Myl4, it is worth noting that previous studies have reported that loss-of-function models of Myl4 exhibit morphological and electrical remodeling, leading to the development of arrhythmias [42,43]. Therefore, SNPiP may play a protective role in cardiac functions by upregulating Myl4 to suppress these remodeling processes.…”
mentioning
confidence: 96%
“…A study by Peng et al [49] underscored a key role of MYL4 for atrial contractile, electrical and structural integrity via positive regulation of ATPase activity, enabling actin monomer binding. Variants in this gene were shown to cause progressive atrial fibrosis, leading to atrial cardiomyopathy and familial AF in humans and rats, while MYL4 loss-of-function was shown to block autophagy flux in atrial cardiomyocytes [50,51]. The other candidate modulator of RPL3L, SDHA, encodes a flavoprotein, a major catalytic subunit of the succinate dehydrogenase (SDH) enzyme, which is a key complex II protein of the mitochondrial respiratory chain that links two important pathways of ATP production in mitochondria, the Krebs cycle and oxidative phosphorylation.…”
Section: Discussionmentioning
confidence: 99%
“…Its expression product possesses Ca 2+ binding and motor activity, participating in the structural components of skeletal muscle, and is associated with muscle development and sarcomere contraction [12]. The most current research on the MYL4 gene focuses on cardiomyopathy [13,14]. However, with the continuous advancement of omics sciences, more evidence suggests the association of the MYL4 gene with muscle growth and development [15].…”
Section: Introductionmentioning
confidence: 99%